Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
5.17
+0.14 (2.78%)
Aug 29, 2025, 4:11 PM AEST

Mayne Pharma Group Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
408.1388.4183.59157.15400.78
Upgrade
Revenue Growth (YoY)
5.07%111.56%16.82%-60.79%-12.30%
Upgrade
Cost of Revenue
160.82169.62100.185.58218.8
Upgrade
Gross Profit
247.27218.7883.4971.57181.98
Upgrade
Selling, General & Admin
251.4276.38251.19181.89172.69
Upgrade
Research & Development
17.9120.2415.7312.2121.69
Upgrade
Operating Expenses
269.3296.61266.92194.1194.38
Upgrade
Operating Income
-22.03-77.84-183.43-122.53-12.4
Upgrade
Interest Expense
-39.8-35-10.42-10.7-12.02
Upgrade
Interest & Investment Income
4.917.076.720.460.69
Upgrade
Currency Exchange Gain (Loss)
2.13-0.53-9.520.85-1.92
Upgrade
Other Non Operating Income (Expenses)
1.721.11-13.98-16-19.73
Upgrade
EBT Excluding Unusual Items
-53.07-105.2-210.63-147.91-45.38
Upgrade
Merger & Restructuring Charges
-1.63-0.89-12.15-5.01-9.5
Upgrade
Gain (Loss) on Sale of Assets
---3.74-
Upgrade
Asset Writedown
---69.18-68.29-229.32
Upgrade
Legal Settlements
-12.05-1.33-5.09-2.89-2.12
Upgrade
Other Unusual Items
-16.56-82.6723.974.7722.43
Upgrade
Pretax Income
-83.3-190.09-269.7-145.59-263.89
Upgrade
Income Tax Expense
6.78-21.4747.7574.5-54.81
Upgrade
Earnings From Continuing Operations
-90.07-168.62-317.44-220.09-209.08
Upgrade
Earnings From Discontinued Operations
-3.77-5.61434.6-71.81-
Upgrade
Net Income to Company
-93.84-174.23117.16-291.89-209.08
Upgrade
Minority Interest in Earnings
--0.0910.610.66
Upgrade
Net Income
-93.84-174.23117.25-281.29-208.42
Upgrade
Net Income to Common
-93.84-174.23117.25-281.29-208.42
Upgrade
Shares Outstanding (Basic)
7980828279
Upgrade
Shares Outstanding (Diluted)
7980828279
Upgrade
Shares Change (YoY)
-0.60%-3.11%-0.15%4.74%2.75%
Upgrade
EPS (Basic)
-1.19-2.191.43-3.42-2.65
Upgrade
EPS (Diluted)
-1.19-2.191.43-3.42-2.65
Upgrade
Free Cash Flow
5.19-23.25-51.05-17.2241.77
Upgrade
Free Cash Flow Per Share
0.07-0.29-0.62-0.210.53
Upgrade
Gross Margin
60.59%56.33%45.48%45.54%45.41%
Upgrade
Operating Margin
-5.40%-20.04%-99.92%-77.97%-3.09%
Upgrade
Profit Margin
-22.99%-44.86%63.87%-179.00%-52.00%
Upgrade
Free Cash Flow Margin
1.27%-5.99%-27.81%-10.96%10.42%
Upgrade
EBITDA
42.08-14.5-116.53-46.3450.04
Upgrade
EBITDA Margin
10.31%-3.73%-63.48%-29.49%12.49%
Upgrade
D&A For EBITDA
64.1163.3366.976.1962.45
Upgrade
EBIT
-22.03-77.84-183.43-122.53-12.4
Upgrade
EBIT Margin
-5.40%-20.04%-99.92%-77.97%-3.09%
Upgrade
Revenue as Reported
408.1388.4183.59157.15400.78
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.